All episodes

In this episode, Elisa Canu speaks with Sophie Scott.

In this week’s episode, Elka Stefanova and Marua Panozzo Chiomento discuss how Parkinson’s disease affects language and communication.

Moderator: Elka Stefanova (Belgrade, Serbia)

Guest: Stefano Francesco Cappa (Milan, Italy)

In this episode, Elka Stefanova speaks with Stefano Francesco Cappa about the relationship between language and the motor system and its implications for the evolution and neural organisation of language. They discuss evidence from cognitive neuroscience, neuroanatomy, and neurodegenerative disorders, highlighting the role of sensorimotor processes in semantic representation and acquired language dysfunction in neurological practice.

Moderator: Elisa Canu (Milan, Italy)

Guest: Cornelius Weiller (Freiburg, Germany)

In this episode, Elisa Canu speaks with Cornelius Weiller about the neural architecture underlying language, concept formation, and the brain’s interaction with the environment. They discuss the role of dorsal, ventral, and semantic pathways, convergence hubs, and their relevance for understanding language processing, cognition, and neurological disorders affecting communication and higher cortical functions.

Moderator: Gail Kinman (London, UK)

Guest: Alice Accorroni (Geneva, Switzerland)

In this episode, Alice Accorroni speaks with Gail Kinman about burnout in healthcare and the role of occupational health psychology in its prevention and management. They discuss the definition and recognition of burnout, key warning signs, and the importance of organisational factors, workplace culture, and leadership in supporting clinician wellbeing and maintaining safe neurological practice.

Moderator: Cláudia Santos Silva (Lisbon, Portugal)

Guest: Andrea Calvo (Turin, Italy)

In this episode, Cláudia Santos Silva speaks with Andrea Calvo about the genetics of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). They discuss the shared genetic basis of these disorders, key disease-associated genes, and the role of genetic testing, counselling, and result interpretation in clinical practice, highlighting how genetic discoveries are advancing precision medicine and emerging gene-targeted therapies in ALS and FTD.

Moderator: Raffaele Dubbioso (Naples, Italy)

Guest: Andrea Malaspina (London, UK) and Francesco Di Lorenzo (Rome, Italy)

In this episode, Raffaele Dubbioso speaks with Andrea Malaspina and Francesco Di Lorenzo about the growing role of neurofilaments as biomarkers in amyotrophic lateral sclerosis and frontotemporal dementia. They discuss the biological basis and clinical interpretation of neurofilament measurements, their diagnostic and prognostic value, and their emerging role in identifying pre-symptomatic disease, monitoring progression, and supporting clinical trials in neurological practice.

Moderator: Elisa Canu (Milan, Italy)

Guest: Anna Gilioli (Milan, Italy)

In this episode, Elisa Canu speaks with Anna Gilioli about social cognition impairment in amyotrophic lateral sclerosis (ALS). They discuss its clinical manifestations, underlying neurobiological mechanisms, and assessment approaches, highlighting the importance of early recognition and its implications for patient management, prognosis, and multidisciplinary neurological care.

Moderator: Valentina Iuzzolino (Naples, Italy)

Guest: Elka Stefanova (Belgrade, Serbia) and Mamede de Carvalho (Lisbon, Porugal)

In this episode, Valentina Iuzzolino speaks with Elka Stefanova and Mamede de Carvalho about diagnostic challenges in amyotrophic lateral sclerosis and frontotemporal dementia. They discuss clinical heterogeneity, key differential diagnoses and red flags, the role of Gold Coast criteria and neurophysiology in ALS, and the importance of longitudinal clinical assessment and neuroimaging in distinguishing frontotemporal dementia from primary psychiatric disorders.

Moderator: Raphael Wurm (Vienna, Austria)

Guest: Roland Wiest (Bern, Switzerland)

In this episode, Raphael Wurm speaks with Roland Wiest about how the AI revolution is set to reshape the clinical environment in neurology. They discuss the areas where augmentation and automation are likely to have the greatest impact, including neuroimaging, clinical workflows, and decision support, while exploring how neurologists can prepare themselves and their institutions to translate emerging AI technologies into meaningful improvements for both clinicians and patients.